1 unknown, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
Follow Stage III Vulvar Cancer AJCC v7: new trials by email Literature Review of Stage III Vulvar Cancer AJCC v7 trials Research Report on Stage III Vulvar Cancer AJCC v7
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma Conventional Surgery, Ipilimumab, Laboratory Biomarker Analysis - Cervical Carcinoma, Esophageal Carcinoma | Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2017-11-03 | 2018-10-03 | |
| Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva Cisplatin, Gemcitabine Hydrochloride, Intensity-Modulated Radiation Therapy - Stage III Vulvar Cancer AJCC v7, Stage IIIA Vulvar Cancer AJCC v7 | Phase 2 | Unknown | Gynecologic Oncology Group | 57 | 2012-07-02 | 2021-12-29 |
Vulvar Neoplasms (2) · Esophageal Neoplasms (1) · Melanoma (1) · Uterine Cervical Neoplasms (1) · Vaginal Neoplasms (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasms (2) · Neoplasms by Site (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Vulvar Diseases (2) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1)
1,2-diaminocyclohexaneplatinum II citrate (1) · CTLA-4 Antigen (1) · Cisplatin (1) · Gemcitabine (1) · Ipilimumab (1) · Nivolumab (1) · Observation (1) · Platinum (1) · Radiation (1) · Radiotherapy (1) · Radiotherapy, Intensity-Modulated (1) · Watchful Waiting (1)
Gynecologic Oncology Group (1) · National Cancer Institute (NCI) (1)
United States (2)
Alexander Shoushtari (1) · Neil S Horowitz (1)
U10CA027469 (1), U10CA180821 (1), U10CA180868 (1)